Global Acute Migraine Drugs Supply, Demand and Key Producers, 2024-2030

Description

The global Acute Migraine Drugs market size is expected to reach $ 3473.9 million by 2030, rising at a market growth of 7.0% CAGR during the forecast period (2024-2030).

The top 3 manufacturers held about 29.5% of the market share in 2019, while top 5 hold 41.93%.

A migraine is an episodic and unpredictable headache disorder that presents with disabling attack. Migraine is one of the most frequent disabling neurological conditions with a major impact on the patient’s quality of life. Migraine has been described as a chronic disorder that characterized with attacks. Attacks are characterized by moderate–severe, often unilateral, pulsating headache attacks, typically lasting 4 to 72 hours.

This report studies the global Acute Migraine Drugs production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Acute Migraine Drugs, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Acute Migraine Drugs that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Acute Migraine Drugs total production and demand, 2019-2030, (K Unit)
Global Acute Migraine Drugs total production value, 2019-2030, (USD Million)
Global Acute Migraine Drugs production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (K Unit)
Global Acute Migraine Drugs consumption by region & country, CAGR, 2019-2030 & (K Unit)
U.S. VS China: Acute Migraine Drugs domestic production, consumption, key domestic manufacturers and share
Global Acute Migraine Drugs production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (K Unit)
Global Acute Migraine Drugs production by Type, production, value, CAGR, 2019-2030, (USD Million) & (K Unit)
Global Acute Migraine Drugs production by Application production, value, CAGR, 2019-2030, (USD Million) & (K Unit).

This reports profiles key players in the global Acute Migraine Drugs market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GSK, Teva, Pfizer, Novartis, Sun Pharma, Grunenthal, Endo Pharmaceuticals, Merck and J & J, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Acute Migraine Drugs market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Unit) and average price (USD/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Acute Migraine Drugs Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Acute Migraine Drugs Market, Segmentation by Type
    Triptans
    NSAIDs
    Others

Global Acute Migraine Drugs Market, Segmentation by Application
    Hospital Pharmacies
    Drug Stores

Companies Profiled:
    GSK
    Teva
    Pfizer
    Novartis
    Sun Pharma
    Grunenthal
    Endo Pharmaceuticals
    Merck
    J & J

Key Questions Answered
1. How big is the global Acute Migraine Drugs market?
2. What is the demand of the global Acute Migraine Drugs market?
3. What is the year over year growth of the global Acute Migraine Drugs market?
4. What is the production and production value of the global Acute Migraine Drugs market?
5. Who are the key producers in the global Acute Migraine Drugs market?

Table of Contents

1 Supply Summary
    1.1 Acute Migraine Drugs Introduction
    1.2 World Acute Migraine Drugs Supply & Forecast
        1.2.1 World Acute Migraine Drugs Production Value (2019 & 2023 & 2030)
        1.2.2 World Acute Migraine Drugs Production (2019-2030)
        1.2.3 World Acute Migraine Drugs Pricing Trends (2019-2030)
    1.3 World Acute Migraine Drugs Production by Region (Based on Production Site)
        1.3.1 World Acute Migraine Drugs Production Value by Region (2019-2030)
        1.3.2 World Acute Migraine Drugs Production by Region (2019-2030)
        1.3.3 World Acute Migraine Drugs Average Price by Region (2019-2030)
        1.3.4 North America Acute Migraine Drugs Production (2019-2030)
        1.3.5 Europe Acute Migraine Drugs Production (2019-2030)
        1.3.6 China Acute Migraine Drugs Production (2019-2030)
        1.3.7 Japan Acute Migraine Drugs Production (2019-2030)
        1.3.8 Middle East Acute Migraine Drugs Production (2019-2030)
        1.3.9 India Acute Migraine Drugs Production (2019-2030)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Acute Migraine Drugs Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Acute Migraine Drugs Major Market Trends

2 Demand Summary
    2.1 World Acute Migraine Drugs Demand (2019-2030)
    2.2 World Acute Migraine Drugs Consumption by Region
        2.2.1 World Acute Migraine Drugs Consumption by Region (2019-2024)
        2.2.2 World Acute Migraine Drugs Consumption Forecast by Region (2025-2030)
    2.3 United States Acute Migraine Drugs Consumption (2019-2030)
    2.4 China Acute Migraine Drugs Consumption (2019-2030)
    2.5 Europe Acute Migraine Drugs Consumption (2019-2030)
    2.6 Japan Acute Migraine Drugs Consumption (2019-2030)
    2.7 South Korea Acute Migraine Drugs Consumption (2019-2030)
    2.8 ASEAN Acute Migraine Drugs Consumption (2019-2030)
    2.9 India Acute Migraine Drugs Consumption (2019-2030)

3 World Acute Migraine Drugs Manufacturers Competitive Analysis
    3.1 World Acute Migraine Drugs Production Value by Manufacturer (2019-2024)
    3.2 World Acute Migraine Drugs Production by Manufacturer (2019-2024)
    3.3 World Acute Migraine Drugs Average Price by Manufacturer (2019-2024)
    3.4 Acute Migraine Drugs Company Evaluation Quadrant
    3.5 Industry Rank and Concentration Rate (CR)
        3.5.1 Global Acute Migraine Drugs Industry Rank of Major Manufacturers
        3.5.2 Global Concentration Ratios (CR4) for Acute Migraine Drugs in 2023
        3.5.3 Global Concentration Ratios (CR8) for Acute Migraine Drugs in 2023
    3.6 Acute Migraine Drugs Market: Overall Company Footprint Analysis
        3.6.1 Acute Migraine Drugs Market: Region Footprint
        3.6.2 Acute Migraine Drugs Market: Company Product Type Footprint
        3.6.3 Acute Migraine Drugs Market: Company Product Application Footprint
    3.7 Competitive Environment
        3.7.1 Historical Structure of the Industry
        3.7.2 Barriers of Market Entry
        3.7.3 Factors of Competition
    3.8 New Entrant and Capacity Expansion Plans
    3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
    4.1 United States VS China: Acute Migraine Drugs Production Value Comparison
        4.1.1 United States VS China: Acute Migraine Drugs Production Value Comparison (2019 & 2023 & 2030)
        4.1.2 United States VS China: Acute Migraine Drugs Production Value Market Share Comparison (2019 & 2023 & 2030)
    4.2 United States VS China: Acute Migraine Drugs Production Comparison
        4.2.1 United States VS China: Acute Migraine Drugs Production Comparison (2019 & 2023 & 2030)
        4.2.2 United States VS China: Acute Migraine Drugs Production Market Share Comparison (2019 & 2023 & 2030)
    4.3 United States VS China: Acute Migraine Drugs Consumption Comparison
        4.3.1 United States VS China: Acute Migraine Drugs Consumption Comparison (2019 & 2023 & 2030)
        4.3.2 United States VS China: Acute Migraine Drugs Consumption Market Share Comparison (2019 & 2023 & 2030)
    4.4 United States Based Acute Migraine Drugs Manufacturers and Market Share, 2019-2024
        4.4.1 United States Based Acute Migraine Drugs Manufacturers, Headquarters and Production Site (States, Country)
        4.4.2 United States Based Manufacturers Acute Migraine Drugs Production Value (2019-2024)
        4.4.3 United States Based Manufacturers Acute Migraine Drugs Production (2019-2024)
    4.5 China Based Acute Migraine Drugs Manufacturers and Market Share
        4.5.1 China Based Acute Migraine Drugs Manufacturers, Headquarters and Production Site (Province, Country)
        4.5.2 China Based Manufacturers Acute Migraine Drugs Production Value (2019-2024)
        4.5.3 China Based Manufacturers Acute Migraine Drugs Production (2019-2024)
    4.6 Rest of World Based Acute Migraine Drugs Manufacturers and Market Share, 2019-2024
        4.6.1 Rest of World Based Acute Migraine Drugs Manufacturers, Headquarters and Production Site (State, Country)
        4.6.2 Rest of World Based Manufacturers Acute Migraine Drugs Production Value (2019-2024)
        4.6.3 Rest of World Based Manufacturers Acute Migraine Drugs Production (2019-2024)

5 Market Analysis by Type
    5.1 World Acute Migraine Drugs Market Size Overview by Type: 2019 VS 2023 VS 2030
    5.2 Segment Introduction by Type
        5.2.1 Triptans
        5.2.2 NSAIDs
        5.2.3 Others
    5.3 Market Segment by Type
        5.3.1 World Acute Migraine Drugs Production by Type (2019-2030)
        5.3.2 World Acute Migraine Drugs Production Value by Type (2019-2030)
        5.3.3 World Acute Migraine Drugs Average Price by Type (2019-2030)

6 Market Analysis by Application
    6.1 World Acute Migraine Drugs Market Size Overview by Application: 2019 VS 2023 VS 2030
    6.2 Segment Introduction by Application
        6.2.1 Hospital Pharmacies
        6.2.2 Drug Stores
    6.3 Market Segment by Application
        6.3.1 World Acute Migraine Drugs Production by Application (2019-2030)
        6.3.2 World Acute Migraine Drugs Production Value by Application (2019-2030)
        6.3.3 World Acute Migraine Drugs Average Price by Application (2019-2030)

7 Company Profiles
    7.1 GSK
        7.1.1 GSK Details
        7.1.2 GSK Major Business
        7.1.3 GSK Acute Migraine Drugs Product and Services
        7.1.4 GSK Acute Migraine Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.1.5 GSK Recent Developments/Updates
        7.1.6 GSK Competitive Strengths & Weaknesses
    7.2 Teva
        7.2.1 Teva Details
        7.2.2 Teva Major Business
        7.2.3 Teva Acute Migraine Drugs Product and Services
        7.2.4 Teva Acute Migraine Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.2.5 Teva Recent Developments/Updates
        7.2.6 Teva Competitive Strengths & Weaknesses
    7.3 Pfizer
        7.3.1 Pfizer Details
        7.3.2 Pfizer Major Business
        7.3.3 Pfizer Acute Migraine Drugs Product and Services
        7.3.4 Pfizer Acute Migraine Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.3.5 Pfizer Recent Developments/Updates
        7.3.6 Pfizer Competitive Strengths & Weaknesses
    7.4 Novartis
        7.4.1 Novartis Details
        7.4.2 Novartis Major Business
        7.4.3 Novartis Acute Migraine Drugs Product and Services
        7.4.4 Novartis Acute Migraine Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.4.5 Novartis Recent Developments/Updates
        7.4.6 Novartis Competitive Strengths & Weaknesses
    7.5 Sun Pharma
        7.5.1 Sun Pharma Details
        7.5.2 Sun Pharma Major Business
        7.5.3 Sun Pharma Acute Migraine Drugs Product and Services
        7.5.4 Sun Pharma Acute Migraine Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.5.5 Sun Pharma Recent Developments/Updates
        7.5.6 Sun Pharma Competitive Strengths & Weaknesses
    7.6 Grunenthal
        7.6.1 Grunenthal Details
        7.6.2 Grunenthal Major Business
        7.6.3 Grunenthal Acute Migraine Drugs Product and Services
        7.6.4 Grunenthal Acute Migraine Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.6.5 Grunenthal Recent Developments/Updates
        7.6.6 Grunenthal Competitive Strengths & Weaknesses
    7.7 Endo Pharmaceuticals
        7.7.1 Endo Pharmaceuticals Details
        7.7.2 Endo Pharmaceuticals Major Business
        7.7.3 Endo Pharmaceuticals Acute Migraine Drugs Product and Services
        7.7.4 Endo Pharmaceuticals Acute Migraine Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.7.5 Endo Pharmaceuticals Recent Developments/Updates
        7.7.6 Endo Pharmaceuticals Competitive Strengths & Weaknesses
    7.8 Merck
        7.8.1 Merck Details
        7.8.2 Merck Major Business
        7.8.3 Merck Acute Migraine Drugs Product and Services
        7.8.4 Merck Acute Migraine Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.8.5 Merck Recent Developments/Updates
        7.8.6 Merck Competitive Strengths & Weaknesses
    7.9 J & J
        7.9.1 J & J Details
        7.9.2 J & J Major Business
        7.9.3 J & J Acute Migraine Drugs Product and Services
        7.9.4 J & J Acute Migraine Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.9.5 J & J Recent Developments/Updates
        7.9.6 J & J Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Acute Migraine Drugs Industry Chain
    8.2 Acute Migraine Drugs Upstream Analysis
        8.2.1 Acute Migraine Drugs Core Raw Materials
        8.2.2 Main Manufacturers of Acute Migraine Drugs Core Raw Materials
    8.3 Midstream Analysis
    8.4 Downstream Analysis
    8.5 Acute Migraine Drugs Production Mode
    8.6 Acute Migraine Drugs Procurement Model
    8.7 Acute Migraine Drugs Industry Sales Model and Sales Channels
        8.7.1 Acute Migraine Drugs Sales Model
        8.7.2 Acute Migraine Drugs Typical Customers

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Acute Migraine Drugs Production Value by Region (2019, 2023 and 2030) & (USD Million)
    Table 2. World Acute Migraine Drugs Production Value by Region (2019-2024) & (USD Million)
    Table 3. World Acute Migraine Drugs Production Value by Region (2025-2030) & (USD Million)
    Table 4. World Acute Migraine Drugs Production Value Market Share by Region (2019-2024)
    Table 5. World Acute Migraine Drugs Production Value Market Share by Region (2025-2030)
    Table 6. World Acute Migraine Drugs Production by Region (2019-2024) & (K Unit)
    Table 7. World Acute Migraine Drugs Production by Region (2025-2030) & (K Unit)
    Table 8. World Acute Migraine Drugs Production Market Share by Region (2019-2024)
    Table 9. World Acute Migraine Drugs Production Market Share by Region (2025-2030)
    Table 10. World Acute Migraine Drugs Average Price by Region (2019-2024) & (USD/Unit)
    Table 11. World Acute Migraine Drugs Average Price by Region (2025-2030) & (USD/Unit)
    Table 12. Acute Migraine Drugs Major Market Trends
    Table 13. World Acute Migraine Drugs Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (K Unit)
    Table 14. World Acute Migraine Drugs Consumption by Region (2019-2024) & (K Unit)
    Table 15. World Acute Migraine Drugs Consumption Forecast by Region (2025-2030) & (K Unit)
    Table 16. World Acute Migraine Drugs Production Value by Manufacturer (2019-2024) & (USD Million)
    Table 17. Production Value Market Share of Key Acute Migraine Drugs Producers in 2023
    Table 18. World Acute Migraine Drugs Production by Manufacturer (2019-2024) & (K Unit)
    Table 19. Production Market Share of Key Acute Migraine Drugs Producers in 2023
    Table 20. World Acute Migraine Drugs Average Price by Manufacturer (2019-2024) & (USD/Unit)
    Table 21. Global Acute Migraine Drugs Company Evaluation Quadrant
    Table 22. World Acute Migraine Drugs Industry Rank of Major Manufacturers, Based on Production Value in 2023
    Table 23. Head Office and Acute Migraine Drugs Production Site of Key Manufacturer
    Table 24. Acute Migraine Drugs Market: Company Product Type Footprint
    Table 25. Acute Migraine Drugs Market: Company Product Application Footprint
    Table 26. Acute Migraine Drugs Competitive Factors
    Table 27. Acute Migraine Drugs New Entrant and Capacity Expansion Plans
    Table 28. Acute Migraine Drugs Mergers & Acquisitions Activity
    Table 29. United States VS China Acute Migraine Drugs Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
    Table 30. United States VS China Acute Migraine Drugs Production Comparison, (2019 & 2023 & 2030) & (K Unit)
    Table 31. United States VS China Acute Migraine Drugs Consumption Comparison, (2019 & 2023 & 2030) & (K Unit)
    Table 32. United States Based Acute Migraine Drugs Manufacturers, Headquarters and Production Site (States, Country)
    Table 33. United States Based Manufacturers Acute Migraine Drugs Production Value, (2019-2024) & (USD Million)
    Table 34. United States Based Manufacturers Acute Migraine Drugs Production Value Market Share (2019-2024)
    Table 35. United States Based Manufacturers Acute Migraine Drugs Production (2019-2024) & (K Unit)
    Table 36. United States Based Manufacturers Acute Migraine Drugs Production Market Share (2019-2024)
    Table 37. China Based Acute Migraine Drugs Manufacturers, Headquarters and Production Site (Province, Country)
    Table 38. China Based Manufacturers Acute Migraine Drugs Production Value, (2019-2024) & (USD Million)
    Table 39. China Based Manufacturers Acute Migraine Drugs Production Value Market Share (2019-2024)
    Table 40. China Based Manufacturers Acute Migraine Drugs Production (2019-2024) & (K Unit)
    Table 41. China Based Manufacturers Acute Migraine Drugs Production Market Share (2019-2024)
    Table 42. Rest of World Based Acute Migraine Drugs Manufacturers, Headquarters and Production Site (States, Country)
    Table 43. Rest of World Based Manufacturers Acute Migraine Drugs Production Value, (2019-2024) & (USD Million)
    Table 44. Rest of World Based Manufacturers Acute Migraine Drugs Production Value Market Share (2019-2024)
    Table 45. Rest of World Based Manufacturers Acute Migraine Drugs Production (2019-2024) & (K Unit)
    Table 46. Rest of World Based Manufacturers Acute Migraine Drugs Production Market Share (2019-2024)
    Table 47. World Acute Migraine Drugs Production Value by Type, (USD Million), 2019 & 2023 & 2030
    Table 48. World Acute Migraine Drugs Production by Type (2019-2024) & (K Unit)
    Table 49. World Acute Migraine Drugs Production by Type (2025-2030) & (K Unit)
    Table 50. World Acute Migraine Drugs Production Value by Type (2019-2024) & (USD Million)
    Table 51. World Acute Migraine Drugs Production Value by Type (2025-2030) & (USD Million)
    Table 52. World Acute Migraine Drugs Average Price by Type (2019-2024) & (USD/Unit)
    Table 53. World Acute Migraine Drugs Average Price by Type (2025-2030) & (USD/Unit)
    Table 54. World Acute Migraine Drugs Production Value by Application, (USD Million), 2019 & 2023 & 2030
    Table 55. World Acute Migraine Drugs Production by Application (2019-2024) & (K Unit)
    Table 56. World Acute Migraine Drugs Production by Application (2025-2030) & (K Unit)
    Table 57. World Acute Migraine Drugs Production Value by Application (2019-2024) & (USD Million)
    Table 58. World Acute Migraine Drugs Production Value by Application (2025-2030) & (USD Million)
    Table 59. World Acute Migraine Drugs Average Price by Application (2019-2024) & (USD/Unit)
    Table 60. World Acute Migraine Drugs Average Price by Application (2025-2030) & (USD/Unit)
    Table 61. GSK Basic Information, Manufacturing Base and Competitors
    Table 62. GSK Major Business
    Table 63. GSK Acute Migraine Drugs Product and Services
    Table 64. GSK Acute Migraine Drugs Production (K Unit), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 65. GSK Recent Developments/Updates
    Table 66. GSK Competitive Strengths & Weaknesses
    Table 67. Teva Basic Information, Manufacturing Base and Competitors
    Table 68. Teva Major Business
    Table 69. Teva Acute Migraine Drugs Product and Services
    Table 70. Teva Acute Migraine Drugs Production (K Unit), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 71. Teva Recent Developments/Updates
    Table 72. Teva Competitive Strengths & Weaknesses
    Table 73. Pfizer Basic Information, Manufacturing Base and Competitors
    Table 74. Pfizer Major Business
    Table 75. Pfizer Acute Migraine Drugs Product and Services
    Table 76. Pfizer Acute Migraine Drugs Production (K Unit), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 77. Pfizer Recent Developments/Updates
    Table 78. Pfizer Competitive Strengths & Weaknesses
    Table 79. Novartis Basic Information, Manufacturing Base and Competitors
    Table 80. Novartis Major Business
    Table 81. Novartis Acute Migraine Drugs Product and Services
    Table 82. Novartis Acute Migraine Drugs Production (K Unit), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 83. Novartis Recent Developments/Updates
    Table 84. Novartis Competitive Strengths & Weaknesses
    Table 85. Sun Pharma Basic Information, Manufacturing Base and Competitors
    Table 86. Sun Pharma Major Business
    Table 87. Sun Pharma Acute Migraine Drugs Product and Services
    Table 88. Sun Pharma Acute Migraine Drugs Production (K Unit), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 89. Sun Pharma Recent Developments/Updates
    Table 90. Sun Pharma Competitive Strengths & Weaknesses
    Table 91. Grunenthal Basic Information, Manufacturing Base and Competitors
    Table 92. Grunenthal Major Business
    Table 93. Grunenthal Acute Migraine Drugs Product and Services
    Table 94. Grunenthal Acute Migraine Drugs Production (K Unit), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 95. Grunenthal Recent Developments/Updates
    Table 96. Grunenthal Competitive Strengths & Weaknesses
    Table 97. Endo Pharmaceuticals Basic Information, Manufacturing Base and Competitors
    Table 98. Endo Pharmaceuticals Major Business
    Table 99. Endo Pharmaceuticals Acute Migraine Drugs Product and Services
    Table 100. Endo Pharmaceuticals Acute Migraine Drugs Production (K Unit), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 101. Endo Pharmaceuticals Recent Developments/Updates
    Table 102. Endo Pharmaceuticals Competitive Strengths & Weaknesses
    Table 103. Merck Basic Information, Manufacturing Base and Competitors
    Table 104. Merck Major Business
    Table 105. Merck Acute Migraine Drugs Product and Services
    Table 106. Merck Acute Migraine Drugs Production (K Unit), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 107. Merck Recent Developments/Updates
    Table 108. J & J Basic Information, Manufacturing Base and Competitors
    Table 109. J & J Major Business
    Table 110. J & J Acute Migraine Drugs Product and Services
    Table 111. J & J Acute Migraine Drugs Production (K Unit), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 112. Global Key Players of Acute Migraine Drugs Upstream (Raw Materials)
    Table 113. Acute Migraine Drugs Typical Customers
    Table 114. Acute Migraine Drugs Typical Distributors
List of Figure
    Figure 1. Acute Migraine Drugs Picture
    Figure 2. World Acute Migraine Drugs Production Value: 2019 & 2023 & 2030, (USD Million)
    Figure 3. World Acute Migraine Drugs Production Value and Forecast (2019-2030) & (USD Million)
    Figure 4. World Acute Migraine Drugs Production (2019-2030) & (K Unit)
    Figure 5. World Acute Migraine Drugs Average Price (2019-2030) & (USD/Unit)
    Figure 6. World Acute Migraine Drugs Production Value Market Share by Region (2019-2030)
    Figure 7. World Acute Migraine Drugs Production Market Share by Region (2019-2030)
    Figure 8. North America Acute Migraine Drugs Production (2019-2030) & (K Unit)
    Figure 9. Europe Acute Migraine Drugs Production (2019-2030) & (K Unit)
    Figure 10. China Acute Migraine Drugs Production (2019-2030) & (K Unit)
    Figure 11. Japan Acute Migraine Drugs Production (2019-2030) & (K Unit)
    Figure 12. Middle East Acute Migraine Drugs Production (2019-2030) & (K Unit)
    Figure 13. India Acute Migraine Drugs Production (2019-2030) & (K Unit)
    Figure 14. Acute Migraine Drugs Market Drivers
    Figure 15. Factors Affecting Demand
    Figure 16. World Acute Migraine Drugs Consumption (2019-2030) & (K Unit)
    Figure 17. World Acute Migraine Drugs Consumption Market Share by Region (2019-2030)
    Figure 18. United States Acute Migraine Drugs Consumption (2019-2030) & (K Unit)
    Figure 19. China Acute Migraine Drugs Consumption (2019-2030) & (K Unit)
    Figure 20. Europe Acute Migraine Drugs Consumption (2019-2030) & (K Unit)
    Figure 21. Japan Acute Migraine Drugs Consumption (2019-2030) & (K Unit)
    Figure 22. South Korea Acute Migraine Drugs Consumption (2019-2030) & (K Unit)
    Figure 23. ASEAN Acute Migraine Drugs Consumption (2019-2030) & (K Unit)
    Figure 24. India Acute Migraine Drugs Consumption (2019-2030) & (K Unit)
    Figure 25. Producer Shipments of Acute Migraine Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2023
    Figure 26. Global Four-firm Concentration Ratios (CR4) for Acute Migraine Drugs Markets in 2023
    Figure 27. Global Four-firm Concentration Ratios (CR8) for Acute Migraine Drugs Markets in 2023
    Figure 28. United States VS China: Acute Migraine Drugs Production Value Market Share Comparison (2019 & 2023 & 2030)
    Figure 29. United States VS China: Acute Migraine Drugs Production Market Share Comparison (2019 & 2023 & 2030)
    Figure 30. United States VS China: Acute Migraine Drugs Consumption Market Share Comparison (2019 & 2023 & 2030)
    Figure 31. United States Based Manufacturers Acute Migraine Drugs Production Market Share 2023
    Figure 32. China Based Manufacturers Acute Migraine Drugs Production Market Share 2023
    Figure 33. Rest of World Based Manufacturers Acute Migraine Drugs Production Market Share 2023
    Figure 34. World Acute Migraine Drugs Production Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 35. World Acute Migraine Drugs Production Value Market Share by Type in 2023
    Figure 36. Triptans
    Figure 37. NSAIDs
    Figure 38. Others
    Figure 39. World Acute Migraine Drugs Production Market Share by Type (2019-2030)
    Figure 40. World Acute Migraine Drugs Production Value Market Share by Type (2019-2030)
    Figure 41. World Acute Migraine Drugs Average Price by Type (2019-2030) & (USD/Unit)
    Figure 42. World Acute Migraine Drugs Production Value by Application, (USD Million), 2019 & 2023 & 2030
    Figure 43. World Acute Migraine Drugs Production Value Market Share by Application in 2023
    Figure 44. Hospital Pharmacies
    Figure 45. Drug Stores
    Figure 46. World Acute Migraine Drugs Production Market Share by Application (2019-2030)
    Figure 47. World Acute Migraine Drugs Production Value Market Share by Application (2019-2030)
    Figure 48. World Acute Migraine Drugs Average Price by Application (2019-2030) & (USD/Unit)
    Figure 49. Acute Migraine Drugs Industry Chain
    Figure 50. Acute Migraine Drugs Procurement Model
    Figure 51. Acute Migraine Drugs Sales Model
    Figure 52. Acute Migraine Drugs Sales Channels, Direct Sales, and Distribution
    Figure 53. Methodology
    Figure 54. Research Process and Data Source

Companies Mentioned

GSK
Teva
Pfizer
Novartis
Sun Pharma
Grunenthal
Endo Pharmaceuticals
Merck
J & J